“FDA approval of Tevimbra for the first-line treatment of advanced oesophageal squamous cell carcinoma marks a significant step forward in tackling the unmet needs in this challenging disease are ...

In a Q&A, Dr. Nataliya Uboha discussed how difficulty swallowing may signal esophageal cancer, treatment options and ongoing ...

"Today brings welcome news for many advanced or metastatic oesophageal squamous cell carcinoma patients and oncologists," said Jaffer Ajani of MD Anderson Cancer Centre, CheckMate-648's lead US ...

People with advanced oesophageal and HER-2 negative GEJ cancer have a poor prognosis and no curative treatment options, according to NICE's final appraisal document published this morning.

This can put you at a greater risk of oesophageal cancer ... individuals are at much higher risk of oesophagal cancer (specifically squamous cell carcinoma) from alcohol consumption than ...

Suggested remit: To appraise the clinical and cost effectiveness of Durvalumab + chemoradiation within its marketing authorisation for treating oesophageal cancer (rare disease).

The drug is already approved in the EU to treat certain cases of oesophageal squamous cell carcinoma (ESCC), gastric or gastroesophageal junction (G/GEJ) adenocarcinoma and non-small lung cancer. The ...